Clinical Trial Update: Efficacy Study of Temperature Controlled Laminar Airflow (TLA)-Treatment in Perennial Allergic Asthma [Phase 3]

View source ↗

Summary

Phase 3 efficacy trial evaluating Temperature Controlled Laminar Airflow (TLA) treatment for perennial allergic asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Temperature Controlled Laminar Airflow (TLA) Treatment

Snippet

Sponsor: Airsonett AB | Conditions: Asthma | Phase 3 | Status: COMPLETED